Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job?
RESTRICTED
Published on
Vincent Delatour, Noémie Clouet-Foraisona, Stéphane Jaisson, Patricia Kaiser and Philippe Gillery
Clinical Chemistry and Laboratory Medicine 2019;25(57)10:1623-1631
In this article Delatour and co-authors explore the trueness of external quality assessment (EQA) programmes for determining accuracy of HbA1c testing in diabetes (both lab-based and point-of-care systems). Commutability of processed EQA materials was found to be highly heterogeneou...
Investigating the quality of POCT devices for HbA1c: what are our next steps?
RESTRICTED
Published on
Erna Lenters-Westra and Emma English
Journal of Diabetes Science and Technology 2019;13(6):1154-1157
Lenters-Westra and English consider the pros and cons of different methods for evaluating the performance of HbA1c point-of-care testing (POCT) devices, including:
• CE marking for the European market
• Food and Drug Administration (FDA) clearance for the American market
• International Federation of Clinical Chemistry and Laboratory Medicine (...
Point-of-care testing for HbA1c: clinical need and analytical quality
RESTRICTED
Published on
Emma English, Larissa-Nele Schaffert and Erna Lenters-Westra
Clinical Laboratory International, November 2018
In this article, the authors discuss the benefits of point-of-care testing (POCT), from expediting diagnosis, to ease of monitoring, to cost and time efficiencies in rural and hard-to-reach environments. They go on to explain the different analytical methods for HbA1c measurement, the quality criteria for HbA1c POCT and the quality of P...